Skip to content
healthcare.dev

Duetact

NDC 64764-304, pioglitazone and glimepiride, tablet, from Takeda Pharmaceuticals America, Inc..

Product NDC
64764-304
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021925
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64764-304 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PIOGLITAZONE HYDROCHLORIDE30 mg/1
  • GLIMEPIRIDE4 mg/1

Pharmacologic classes

Peroxisome Proliferator Receptor alpha Agonist [EPC]; Peroxisome Proliferator Receptor gamma Agonist [EPC]; Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]; Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]; Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]; Thiazolidinedione [EPC]; Thiazolidinediones [CS]

Package NDCNDC-11Package
64764-304-306476403043030 TABLET in 1 BOTTLE (64764-304-30)
64764-304-906476403049090 TABLET in 1 BOTTLE (64764-304-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f8b0c917-3fdd-4a28-a47d-6225b8195458

Use it

Look up 64764-304 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64764-304 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64764-304. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.